Three 15,000-share sales reported for Kestra Medical Technologies (NASDAQ: KMTS)

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. reported Form 144 notices relating to 15,000 common shares each sold on 01/15/2026, 02/17/2026, and 03/17/2026. The shares were sold from an account at Merrill Lynch; earlier restricted shares of 15,000 were granted under the issuer's equity compensation plan on 01/21/2026.

Insights

Securities Compliance Analyst

Routine resale notices filed under Rule 144 for small blocks of common stock.

The filing lists three separate sales of 15,000 shares each on 01/15/2026, 02/17/2026, and 03/17/2026

These appear as periodic dispositions from the same holder and reference a restricted grant of 15,000 shares on 01/21/2026. Timing and proceeds are transactional facts; cash‑flow recipients are the selling holder(s).

Key Figures

Sale 1 shares: 15,000 shares Sale 1 proceeds: $342,023.69 Sale 2 shares: 15,000 shares +4 more

7 metrics

Sale 1 shares 15,000 shares Sale on 01/15/2026

Sale 1 proceeds $342,023.69 Proceeds reported for 01/15/2026 sale

Sale 2 shares 15,000 shares Sale on 02/17/2026

Sale 2 proceeds $384,020.06 Proceeds reported for 02/17/2026 sale

Sale 3 shares 15,000 shares Sale on 03/17/2026

Sale 3 proceeds $304,123.49 Proceeds reported for 03/17/2026 sale

Restricted grant 15,000 shares Granted under equity compensation plan on 01/21/2026

Key Terms

Form 144, restricted share issuance, proceeds

3 terms

Form 144 regulatory

"Securities Sold During The Past 3 Months — reporting disposition"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted share issuance financial

"Granted as part of issuer equity compensation plan"

proceeds financial

"Amounts listed next to each sale (e.g., 342023.69)"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	15000	300671.04	58373353	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	01/21/2026	Restricted share issuance	KESTRA MEDICAL TECHNOLOGIES, LTD.			15000	01/21/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Webster 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Shares	01/15/2026	15000	342023.69
Brian Webster 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Shares	02/17/2026	15000	384020.06
Brian Webster 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Shares	03/17/2026	15000	304123.49

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does KMTS Form 144 show about insider sales?

The filing shows three sales of 15,000 shares each on 01/15/2026, 02/17/2026, and 03/17/2026. These are reported dispositions from the same holder and include sale proceeds listed per trade.

Were any restricted shares granted to KMTS in this filing?

Yes. The excerpt records a restricted share grant of 15,000 shares on 01/21/2026 under the issuer's equity compensation plan. The grant date and share count are explicitly listed.

How much cash did the seller report receiving for each KMTS sale?

The filing lists proceeds of $342,023.69, $384,020.06, and $304,123.49 for the three respective sales on the listed dates. Each amount is shown next to the corresponding trade.

Which broker handled the KMTS transactions reported?

The filing identifies Merrill Lynch, 225 Liberty St, Floor 37, New York, NY as the broker/dealer associated with the securities to be sold and the account referenced for the transactions.